The field of pharmacovigilance has undergone a transformative shift with the advent of digital technologies, enabling more proactive and patient-centric drug safety monitoring. In the digital age, innovations such as artificial intelligence (AI), machine learning (ML), and natural language processing (NLP) are enhancing the detection and analysis of adverse drug reactions (ADRs) through diverse data sources like electronic health records (EHRs), social media, and wearable devices. These advancements facilitate real-time surveillance and improve the accuracy of signal detection, ultimately safeguarding public health.
For a comprehensive exploration of how digital technologies are reshaping pharmacovigilance, visit Pharmacovigilance in the Digital Age.
To discover more insights and articles on medical sciences, visit American Hospital & Healthcare Management and explore their Medical Sciences section.
